| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INTIMM/6.8.1177 |
| P698 | PubMed publication ID | 7526890 |
| P50 | author | Jacques Banchereau | Q55097670 |
| Christophe Caux | Q56528905 | ||
| P2093 | author name string | C Barthelemy | |
| Y J Liu | |||
| C Massacrier | |||
| B Vanbervliet | |||
| P433 | issue | 8 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 1177-1185 | |
| P577 | publication date | 1994-08-01 | |
| P1433 | published in | International Immunology | Q15710043 |
| P1476 | title | Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells | |
| P478 | volume | 6 |
| Q37069103 | Adoptive transfer of fibrocytes enhances splenic T-cell numbers and survival in septic peritonitis |
| Q52996542 | Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. |
| Q43584355 | Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance |
| Q54504049 | Anti-CD25 antibodies affect cytokine synthesis pattern of human dendritic cells and decrease their ability to prime allogeneic CD4+ T cells. |
| Q61769621 | Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells |
| Q77627717 | Antigen-presenting cells in rheumatoid arthritis |
| Q24292957 | Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production |
| Q71739878 | CD40-activated human naive surface IgD+ B cells produce IgG2 in response to activated T-cell supernatant |
| Q48526801 | Clinical Development of PD-1 Blockade in Hematologic Malignancies |
| Q37822746 | Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity |
| Q34374026 | Current status of interleukin-10 and regulatory T-cells in cancer |
| Q36569018 | Dendritic cells and tumor microenvironment: a dangerous liaison |
| Q34295082 | Dendritic cells as a tool to induce anergic and regulatory T cells |
| Q33653670 | Dendritic cells. |
| Q33579423 | Dendritic cells: therapeutic potentials |
| Q81082157 | Differential responses of cord and adult blood-derived dendritic cells to dying cells |
| Q24291651 | Differentiation of regulatory T cells 1 is induced by CD2 costimulation |
| Q44033294 | Diltiazem impairs maturation and functions of human dendritic cells |
| Q36597391 | Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer |
| Q39474847 | Effects of Gekko sulfated polysaccharide-protein complex on the defective biorheological characters of dendritic cells under tumor microenvironment |
| Q34118627 | Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. |
| Q36684512 | Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality |
| Q41096075 | Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. |
| Q40851818 | Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. |
| Q42279281 | Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells |
| Q77352709 | IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma |
| Q38127733 | Immune alterations in malignant melanoma and current immunotherapy concepts |
| Q33645590 | Immune checkpoint blockade for hematologic malignancies: a review |
| Q71848361 | Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis |
| Q36256306 | Immunoregulation of dendritic cells |
| Q37233774 | Immunosuppressive networks in the tumour environment and their effect in dendritic cells |
| Q35126556 | Immunotherapy of malignant melanoma |
| Q37374700 | Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii |
| Q44194570 | In vivo administration of 15-deoxyspergulin inhibits antigen-presenting cell stimulation of T cells and NF-kappaB activation |
| Q42495070 | In vivo heparan sulfate treatment alters the immune response of normal and LLC-bearing mice |
| Q52040405 | Increased IL-10 production by stimulated whole blood cultures in primary IgA nephropathy. |
| Q36857931 | Induction of FoxP3+CD4+CD25+ regulatory T cells by a bone marrow population distinct from plasmacytoid-DC. |
| Q40412947 | Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes. |
| Q47912619 | Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects |
| Q41853652 | Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells |
| Q33717191 | Interleukin-10: a cytokine used by tumors to escape immunosurveillance |
| Q41684151 | Interleukin-10: biology, role in inflammation and autoimmunity |
| Q71815204 | Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cells |
| Q77675906 | Langerhans cells do not express alternative macrophage activation-associated CC chemokine (AMAC)-1 |
| Q36371796 | Lipopolysaccharide or Whole Bacteria Block the Conversion of Inflammatory Monocytes into Dendritic Cells In Vivo |
| Q46816706 | Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs |
| Q35968465 | Mechanisms and functional significance of tumour-induced dendritic-cell defects |
| Q38784095 | Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions |
| Q34130104 | Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function |
| Q43137999 | Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile |
| Q56902104 | Natural killer cells prime the responsiveness of autologous CD4+ T cells to CTLA4-Ig and interleukin-10 mediated inhibition in an allogeneic dendritic cell-mixed lymphocyte reaction |
| Q40906220 | Origin, maturation and antigen presenting function of dendritic cells. |
| Q35922431 | Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes. |
| Q34314210 | Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway |
| Q74237814 | Regulation of major histocompatibility complex class II synthesis by interleukin-10 |
| Q38008336 | Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells |
| Q38060836 | Roles of IL-10 in ocular inflammations: a review. |
| Q73043181 | Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step |
| Q46818225 | Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats |
| Q64063170 | The Pivotal Role of Regulatory T Cells in the Regulation of Innate Immune Cells |
| Q40369714 | The ratio between dendritic cells and T cells determines the outcome of their encounter: proliferation versus deletion |
| Q41228239 | The role of cytokines in functional regulation and differentiation of dendritic cells |
| Q34148661 | The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). |
| Q39069841 | Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? |
| Q33926276 | Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production |
| Q35039049 | Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking |
| Q64043010 | Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity |
Search more.